NeoGenomics
NEO
$8.77
Share price
4.47%
Change (1 day)
-76.71%
Change (1 year)
Market capitalization of NeoGenomics (NEO)
Market cap: $1.19 Billion
As of May 2022 NeoGenomics has a market cap of $1.19 Billion. This makes NeoGenomics the world's 4120th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Market cap history of NeoGenomics from 2001 to 2022
| Year | Market cap | Change |
|---|---|---|
| 2022 | $1.21 B | -71.07% |
| 2021 | $4.20 B | -29.72% |
| 2020 | $5.97 B | 95.04% |
| 2019 | $3.06 B | 157.29% |
| 2018 | $1.19 B | 67.2% |
| 2017 | $0.71 B | 5.88% |
| 2016 | $0.67 B | 12.76% |
| 2015 | $0.59 B | 137.53% |
| 2014 | $0.25 B | 41.28% |
| 2013 | $0.17 B | 58.34% |
| 2012 | $0.11 B | 85.52% |
| 2011 | $0.06 B | 24.42% |
| 2010 | $0.04 B | -12.78% |
| 2009 | $0.05 B | 188.34% |
| 2008 | $0.01 B | -42.94% |
| 2007 | $0.03 B | -16.48% |
| 2006 | $0.04 B | 835.52% |
| 2005 | $4.33 M | -19.42% |
| 2004 | $5.38 M | 483.74% |
| 2003 | $0.92 M | -74.27% |
| 2002 | $3.58 M | -40.97% |
| 2001 | $6.07 M |
End of Day market cap according to different sources
On May 18th, 2022 the market cap of NeoGenomics was reported to be:
$1.04 Billion
$1.14 Billion
$1.03 Billion
$1.04 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Quest Diagnostics
DGX | $16.37 B | 1,269.85% | 🇺🇸 USA |
 LabCorp LH | $22.69 B | 1,798.95% | 🇺🇸 USA |
 RadNet RDNT | $1.06 B | -10.69% | 🇺🇸 USA |
 Psychemedics PMD | $0.03 B | -97.05% | 🇺🇸 USA |
 Enzo Biochem ENZ | $0.11 B | -90.46% | 🇺🇸 USA |